Home > Riviste > Minerva Endocrinologica > Fascicoli precedenti > Minerva Endocrinologica 2014 Settembre;39(3) > Minerva Endocrinologica 2014 Settembre;39(3):155-65

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

MINERVA ENDOCRINOLOGICA

Rivista sulle Malattie del Sistema Endocrino


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,118


eTOC

 

  ENDOCRINOLOGIA GINECOLOGICA


Minerva Endocrinologica 2014 Settembre;39(3):155-65

lingua: Inglese

Endometriosis and ovarian cancer: clinical and molecular aspects

Pavlidou A. 1, Vlahos N. F. 1, 2

1 Second Department of Obstetrics and Gynecology, University of Athens Medical School, Aretaieion Hospital, Athens, Greece;
2 Department of Gynecology and Obstetrics, Johns Hopkins Hospital School of Medicine, Baltimore, MD, USA


PDF  


Endometriosis is one of the most commonly encountered benign problems in gynecology. Even though endometriosis appears to predispose to ovarian cancer the progression from atypical epithelial proliferation (atypical endometriosis and metaplasia), to the formation of well-defined borderline tumors and finally to endometrioid ovarian cancer will take several years. To elaborate on the concept of endometriosis as a precursor of some types of ovarian cancer, we present an overview of the pathophysiological and genetic characteristics, common in those two conditions. Furthermore, we present the genetic mutations found in ovarian cancers and we outline the common genetic alterations of endometriosis and ovarian cancer, focusing on the PI3K/Akt/mTOR-signaling pathway.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

thani_pavlidou@yahoo.gr